Acasti Pharma Alpha and Beta Analysis
| ACSTDelisted Stock | USD 3.37 0.01 0.30% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Acasti Pharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in Acasti Pharma over a specified time horizon. Remember, high Acasti Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Acasti Pharma's market risk premium analysis include:
Beta 0.22 | Alpha 0.32 | Risk 5.07 | Sharpe Ratio 0.14 | Expected Return 0.7 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Acasti |
Acasti Pharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Acasti Pharma market risk premium is the additional return an investor will receive from holding Acasti Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Acasti Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Acasti Pharma's performance over market.| α | 0.32 | β | 0.22 |
Acasti Pharma Fundamentals Vs Peers
Comparing Acasti Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Acasti Pharma's direct or indirect competition across all of the common fundamentals between Acasti Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Acasti Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Acasti Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Acasti Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Acasti Pharma to competition |
| Fundamentals | Acasti Pharma | Peer Average |
| Return On Equity | -0.19 | -0.31 |
| Return On Asset | -0.12 | -0.14 |
| Current Valuation | 11.17 M | 16.62 B |
| Shares Outstanding | 10.14 M | 571.82 M |
| Shares Owned By Insiders | 38.39 % | 10.09 % |
| Shares Owned By Institutions | 21.22 % | 39.21 % |
| Number Of Shares Shorted | 154.19 K | 4.71 M |
Acasti Pharma Opportunities
Acasti Pharma Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | ACST Stock Earnings Acasti Pharma Beats EPS for Q1 2025 | 08/09/2024 |
2 | Acasti to Present at the Life Sciences Investor Forum | 09/12/2024 |
3 | Acasti Pharma Share Price Passes Above 200 Day Moving Average Should You Sell | 10/11/2024 |
4 | Acasti Pharma changes name to Grace Therapeutics | 10/25/2024 |
About Acasti Pharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Acasti or other delisted stocks. Alpha measures the amount that position in Acasti Pharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Acasti Pharma Upcoming Company Events
As portrayed in its financial statements, the presentation of Acasti Pharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Acasti Pharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Acasti Pharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Acasti Pharma. Please utilize our Beneish M Score to check the likelihood of Acasti Pharma's management manipulating its earnings.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 28th of June 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of June 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
Build Portfolio with Acasti Pharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Acasti Stock
If you are still planning to invest in Acasti Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acasti Pharma's history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |